AnaptysBio, Inc. (ANAB) Profit Margin
AnaptysBio, Inc. (ANAB) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2017-12-31 | -300.70% |
| 2018-12-31 | -1233.12% |
| 2019-12-31 | -1216.70% |
| 2020-12-31 | -26.57% |
| 2021-12-31 | -91.49% |
| 2022-12-31 | -1251.33% |
| 2023-12-31 | -953.66% |
| 2024-12-31 | -159.10% |
| 2025-12-31 | -5.64% |
How ANAB compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc. | -0.20% |
| HROW | Harrow Inc Com | -1.89% |
| AZTA | Azenta Inc. | -9.39% |
| ACHV | Achieve Life Sciences Inc. | -24.38% |
| NMTC | NeuroOne Medical Technologies Corporation | -39.63% |
These are five companies in the same sector as ANAB with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get AnaptysBio, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("ANAB", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ANAB | $58.47 | +0.00% | 0.27M |
| 3 | ||||
| 4 | ||||
| 5 |